Acalabrutinib in chronic lymphocytic leukemia. 2023

Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.

UI MeSH Term Description Entries
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001549 Benzamides BENZOIC ACID amides.
D015451 Leukemia, Lymphocytic, Chronic, B-Cell A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease. B-Cell Leukemia, Chronic,B-Lymphocytic Leukemia, Chronic,Chronic Lymphocytic Leukemia,Leukemia, B-Cell, Chronic,Leukemia, Lymphocytic, Chronic,Lymphocytic Leukemia, Chronic, B-Cell,Lymphoma, Small Lymphocytic,B-Cell Chronic Lymphocytic Leukemia,B-Cell Malignancy, Low-Grade,Diffuse Well-Differentiated Lymphocytic Lymphoma,Disrupted In B-Cell Malignancy,Leukemia, B Cell, Chronic,Leukemia, Chronic Lymphatic,Leukemia, Chronic Lymphocytic,Leukemia, Chronic Lymphocytic, B-Cell,Leukemia, Lymphoblastic, Chronic,Leukemia, Lymphocytic, Chronic, B Cell,Lymphoblastic Leukemia, Chronic,Lymphocytic Leukemia, Chronic,Lymphocytic Leukemia, Chronic, B Cell,Lymphocytic Lymphoma,Lymphocytic Lymphoma, Diffuse, Well Differentiated,Lymphocytic Lymphoma, Diffuse, Well-Differentiated,Lymphocytic Lymphoma, Well Differentiated,Lymphocytic Lymphoma, Well-Differentiated,Lymphoma, Lymphocytic,Lymphoma, Lymphocytic, Diffuse, Well Differentiated,Lymphoma, Lymphocytic, Diffuse, Well-Differentiated,Lymphoma, Lymphocytic, Well Differentiated,Lymphoma, Lymphocytic, Well-Differentiated,Lymphoma, Lymphoplasmacytoid, CLL,Lymphoma, Small Lymphocytic, Plasmacytoid,Lymphoma, Small-Cell,Lymphoplasmacytoid Lymphoma, CLL,Small-Cell Lymphoma,B Cell Chronic Lymphocytic Leukemia,B Cell Leukemia, Chronic,B Cell Malignancy, Low Grade,B Lymphocytic Leukemia, Chronic,B-Cell Leukemias, Chronic,B-Cell Malignancies, Low-Grade,B-Lymphocytic Leukemias, Chronic,CLL Lymphoplasmacytoid Lymphoma,CLL Lymphoplasmacytoid Lymphomas,Chronic B-Cell Leukemia,Chronic B-Cell Leukemias,Chronic B-Lymphocytic Leukemia,Chronic B-Lymphocytic Leukemias,Chronic Lymphatic Leukemia,Chronic Lymphatic Leukemias,Chronic Lymphoblastic Leukemia,Chronic Lymphoblastic Leukemias,Chronic Lymphocytic Leukemias,Diffuse Well Differentiated Lymphocytic Lymphoma,Disrupted In B Cell Malignancy,Leukemia, Chronic B-Cell,Leukemia, Chronic B-Lymphocytic,Leukemias, Chronic B-Cell,Leukemias, Chronic B-Lymphocytic,Leukemias, Chronic Lymphatic,Leukemias, Chronic Lymphoblastic,Low-Grade B-Cell Malignancies,Low-Grade B-Cell Malignancy,Lymphatic Leukemia, Chronic,Lymphatic Leukemias, Chronic,Lymphoblastic Leukemias, Chronic,Lymphocytic Leukemias, Chronic,Lymphocytic Lymphoma, Small,Lymphocytic Lymphomas,Lymphocytic Lymphomas, Small,Lymphocytic Lymphomas, Well-Differentiated,Lymphoma, CLL Lymphoplasmacytoid,Lymphoma, Small Cell,Lymphoma, Well-Differentiated Lymphocytic,Lymphomas, CLL Lymphoplasmacytoid,Lymphomas, Lymphocytic,Lymphomas, Small Lymphocytic,Lymphomas, Small-Cell,Lymphomas, Well-Differentiated Lymphocytic,Lymphoplasmacytoid Lymphomas, CLL,Malignancies, Low-Grade B-Cell,Malignancy, Low-Grade B-Cell,Small Cell Lymphoma,Small Lymphocytic Lymphoma,Small Lymphocytic Lymphomas,Small-Cell Lymphomas,Well-Differentiated Lymphocytic Lymphoma,Well-Differentiated Lymphocytic Lymphomas
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
June 2021, Blood,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
January 2016, The New England journal of medicine,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
January 2022, Clinical advances in hematology & oncology : H&O,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
December 2022, Leukemia & lymphoma,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
November 2022, Kidney international reports,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
July 2021, Drugs of today (Barcelona, Spain : 1998),
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
February 2019, Future oncology (London, England),
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
January 2021, Therapeutic advances in hematology,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
August 2021, EJHaem,
Enrica Antonia Martino, and Antonella Bruzzese, and Ernesto Vigna, and Enrico Iaccino, and Francesco Mendicino, and Eugenio Lucia, and Virginia Olivito, and Gianfranco Filippelli, and Antonino Neri, and Fortunato Morabito, and Massimo Gentile
January 2021, OncoTargets and therapy,
Copied contents to your clipboard!